GlassScriptPhysician profile
Alex Gorenshtein
NPI 1154383891
$48,394.96
in general payments reported to CMS, 2019-2025
31 companies · $582 in 2025
The $582 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,992 · 2020: $6,258 · 2021: $13K · 2022: $4,153 · 2023: $8,606 · 2024: $7,884 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Honoraria: $5,100 · Food and Beverage: $1,504 · Travel and Lodging: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,124.25 |
| Honoraria | $5,100.00 |
| Food and Beverage | $1,503.82 |
| Travel and Lodging | $343.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novastep INC. | $33,966.82 | 2020-2024 | Fusionframe Ring Lock Circular Fixator, Nexis, Airlock Centrolock |
| Stryker Corporation | $8,036.72 | 2019-2022 | |
| Exactech, INC. | $2,769.75 | 2021-2024 | |
| Medshape, INC. | $1,378.37 | 2023-2024 | Dynanail, Dynanail Helix, Washer, 15 Mm |
| Treace Medical Concepts, INC. | $342.25 | 2023 | |
| Acumed LLC | $218.25 | 2025 | Acumed, Osteomed |
| Linvatec Corporation | $215.53 | 2023-2024 | Colink Afx, Biobrace 23mm |
| Cardiovascular Systems INC. | $171.95 | 2021-2022 | |
| Paragon 28, INC. | $151.07 | 2022-2025 | Precision Mis Bunion |
| Trilliant Surgical LLC. | $137.49 | 2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Ossio INC | $129.60 | 2022 | |
| Depuy Synthes Sales INC. | $115.08 | 2025 | Motoband, Minibunion |
| Biocomposites INC | $111.11 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $103.46 | 2022-2023 | Seglentis |
| Terumo Medical Corporation | $97.85 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $82.42 | 2020-2021 | |
| Kerecis Limited | $49.25 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Tactile Systems Technology INC | $36.06 | 2020-2025 | Nimbl, Flexitouch Plus |
| Horizon Therapeutics Plc | $29.92 | 2021 | |
| Urgo Medical North America, LLC | $29.50 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Nevro Corp. | $24.04 | 2023 | Senza |
| Integra Lifesciences Corporation | $23.95 | 2019 | |
| Averitas Pharma INC. | $23.90 | 2024 | Qutenza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.99 | 2023 | Jublia, Bryhali |
| Bioventus LLC | $22.77 | 2024 | Exogen Ultrasound Bone Healing System |
| Ani Pharmaceuticals, INC. | $21.65 | 2025 | Purified Cortrophin Gel |
| Rikco International, LLC | $19.79 | 2019 | |
| Organogenesis INC. | $18.60 | 2019 | |
| Medtronic, INC. | $17.18 | 2023 | Intellis Adaptivestim |
| Eagle Pharmaceuticals, INC. | $16.55 | 2023 | |
| Merck Sharp & Dohme LLC | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Gorenshtein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.